*1 Scope Remand of Issues on III. INC., LLC, Verispan, HEALTH IMS happen parties dispute what should Analytics, Inc., a Healthcare Source argues government remand. The
upon Health, subsidiary Kluwer of Wolters its have free rein make it should Inc., Pharmaceutical Research and force clause both the case under America, Plain Manufacturers 924(e)(2)(B)(i) residual clause § and the tiffs-Appellants, 924(e)(2)(B)(ii). § The defendants under get government should not argue that the Attorney SORRELL, as Gen William H. apple. two bites at Vermont, Jim eral of the State government’s theory the district capacity Douglas, his official as clause, the force courts based on was Vermont, Governor of State of 924(e)(2)(B)(i). govern- § the time the At capacity Hofmann, in his Robert opportunity to introduce ment had Secretary Agency of Human of the in- beyond the documents Shepard type Vermont, De Services of States theory its but support dictment alone fendants-Appellees. Because, however, both did not so. do 09-1913-cv(L), Docket Nos. district courts were government 09-2056-cv(CON). re- premise Mangos operating on the law, proffer failure to good mained Appeals, States Court of United was than understanda- such evidence more Second Circuit. clause, As the issue of the residual
ble. Oct. Argued: the use party no raised discussed 23, 2010. Decided: Nov. ACCA. that clause under the Under circumstances, no perceive we unfairness government opportuni- allowing force
ty pursue both the clause remand, using
residual clause theories on
Shepard approved documents.
IV. Conclusion above, va- provided
For reasons we appellants and
cate sentences of the resentencing.
remand for *3 Julin, Isani, R. Z. Patri-
Thomas Jamie Acosta, LLP, cia Hunton Mia- & Williams mi, FL; Hemley, B. B. Robert Matthew Shea, P.A., Burlington, & Byrne, Gravel Goldstein, VT; Gump Akin Thomas C. LLP, Washington, Hauer & Feld Strauss DC, IMS Health Plaintiffs-Appellants for Analytics, Inc. Inc. Healthcare and Source Smith, Anderson, Ash, Blount, Mark A. ed District States Court for the District of Dorsett, (J. Jernigan, LLP, Mitchell & Ra- Murtha, Judge) Garvan find NC, leigh, Plaintiff-Appellant Verispan for ing to be a constitutional restric LLC. tion on pursuant Corp. Central Hudson &Gas Electric Weiner, L. Jeffrey
Robert N. Hand- York, Public Service Commission New werker, Arni, Brackney Sarah Arnold & 557, 561-66, U.S. DC; LLP, Washington, Porter Karen (1980), McAndrew, Dinse, finding L.Ed.2d 341 that sec Cohen, J. Knapp Linda McAndrew, P.C., tion 17 VT, does not violate the Burlington, & Commerce *4 Clause, I, 3, Plaintiff-Appellant 8,§ cl. Pharmaceutical Re- art. of the United & search Manufacturers of America. States Constitution.1 IMS Health Inc. v. (D.Vt.2009). Sorrell, F.Supp.2d 434 Sorrell, Attorney H. William General of Vermont; of Bridget Asay, the State C. (1) appeal, appellants argue On the General; Attorney Assistant Sarah E.B. section 17 restricts non-commercial London, Duffy, Kate Cassetty, G. David R. (2) scrutiny, and cannot strict withstand General, brief, Attorneys Assistants on the if that even section 17 restricts com- VT, Montpelier, Defendants-Appellees. for mercial it cannot speech, withstand inter- scrutiny Hudson, mediate under Central Before: FEINBERG and (3) and that section 17 violates dor- LIVINGSTON, Judges, Circuit and mant by Commerce Clause prohibiting KOELTL, Judge.* District wholly commerce outside of Vermont. Judge LIVINGSTON dissents The appellees, Vermont Attorney General separate opinion. Sorrell, H. William Vermont Governor Jim Douglas, Secretary and Agency KOELTL, JOHN G. Judge: District Human Services of the State of Vermont Inc., appellants, IMS Health Veris- (1) Hofmann, Robert contend that section LLC, pan, Analytics, Source Healthcare implicate does not appellants’ First Inc., and Pharmaceutical Research and (2) rights, Amendment if even (“PhRMA”) Manufacturers of America 17 is a appellants’ restriction on the com- (collectively, appellants”) challenge “the mercial speech, section 17 survives inter- sale, banning statute trans- scrutiny narrowly mediate because it is a mission, or prescriber-identifiable use of directly tailored statute that advances Ver- (“PI data”) data promot- for mont’s substantial interest in protecting ing a prescription drug prescri- unless privacy, medical in controlling health care 2007, ber consents. In Vermont enacted costs, health, promoting public and and issue, the statute at namely Vt. Acts No. (3) appellants lack standing to 80, (2007), § 17 codified Vt. Stat. Ann. challenge section 17 under 18, (2007), § the dormant tit. by as amended Vt. that, event, Clause in any Commerce Acts No. 89 (changing effective date § January 17 from section 17 does not violate July the dormant 2009) (Act 17”). appel- “section Commerce Clause in- regulates because appeal judgment lants from a of the Unit- trastate commerce.
* Koeltl, The Honorable John G. upheld United 1. The district court also sections States District Court the Southern appellees District and 21 of Act do not York, by sitting designation. of New challenge holdings appeal. those Vermont, pharmaceutical primarily that because section 17 is We conclude that does manufacturers. The data sold speech restriction appellants data-mining stripped pa- directly advance the substantial state not information, Vermont, priva- protect patient tient and is asserted interests interests, Appellant cy. Pharmaceutical Research narrowly tailored to serve those (“PhRMA”) and Manufacturers of America statute cannot survive intermediate non-profit is a association representing under Hudson. There- scrutiny Central fore, researchers and manufac- judgment and remand the we reverse turers, primary court. customers of district
mining appellants. BACKGROUND Pharmaceutical manufacturers market means, products through their various in- Act 80 legislature passed The Vermont advertising cluding detailing. “Detail- health, 2007, intending protect public ing” by pharmaceutical to visits rep- refers protect prescriber privacy, to re- *5 resentatives, detailers, called to individual 17 prohib- care duce health costs. Section provide to physicians spe- information on sale, license, exchange for value its the or use, prescription drugs, including cific the marketing promoting PI for a or data effects, drug side and risks of interactions. prohibits pharma- drug, and prescription PI Pharmaceutical use manufacturers data manufacturers and marketers ceutical identify to for marketing audiences their marketing using pro- PI data for efforts, marketing messages focus to drug, unless the moting prescription a to prescribers, individual direct scientific Ann. tit. consents. See Vt. Stat. prescriber messages physicians to in safety and most 4631(a) (d). amended, 18, § & As section information, of that to need track disease July 1, 2009. See Vt. was effective on enforcement, to progression, aid law to (2008). Acts No. 89 implement mitigation programs, risk and clinical trials post-market- to conduct and I. the ing required by surveillance United filling pharmacies prescriptions, When Drug and States Food Administration including in Vermont collect information (“FDA”). address, prescriber’s name the and part While section 17 aims de- name, dosage, quantity drug, and of the detailing, prescribers may crease want to and is place the date provide, the information detailers receive filled, age gender. and the patient’s event, and, in any prescribers are free to sell data Pharmacies this data meetings with detailers. decline Inc., mining appellants IMS Health Veris- LLC, noted, Analyt- pharmaceuti- As the court pan, Source Healthcare district ics, mining companies, industry spending detailing These all cal has in- Inc.2 data Vermont, along aggregate exponentially located outside of creased with rise only pre- mining. Detailing data cost- physician data to reveal individual a patterns drugs. and sell it outside of effective for brand-name When scribing rights "pub- pass appellants on information. Their de- 2. describe themselves as lishers,” plainly their pend they they term that furthers what on what do rather than argument. First The district Amendment opinion are called. This will follow the de- appellants as “data min- court, court referred to the by namely scription used the district ers,” a term that has been used in other cases. "data miners.” undisputed appellants It is collect patent expires, competitors can introduce covered section 17 are essential bioequivalent generic drugs. Bioequiva- ability mining appellants data necessarily are generic drugs other, lent provide permitted, PI data for these version, to the name identical brand but uses. required absorption an
are demonstrate percent
rate and 125 between 80 II. drug. absorp- brand-name Variations a. among rates or generic drugs tion branded reactions, may cause different such as side The Vermont law was adopted effects. The district court noted also wake of similar had statute that been drug necessarily while a brand-name is not Hampshire, shortly enacted New generic version, than its better brand- before another similar adopted statute drug typically expensive. name more Maine. Pharmaceutical manufacturers are not In Hampshire 2006 the New legis- state only purchase entities that PI data passed prohibiting lature statute mining appellants,
from the data although patient-identifiable transmission or use of pharmaceutical manufacturers and mar- purposes. and PI data for most commercial keters are the customers banned from See IMS Health Inc. v. Ayotte, 490 using PI data in their efforts (D.N.H.2007), F.Supp.2d rev’d, 170-71 state Vermont itself (1st Cir.2008). In relevant uses PI for law and oth- enforcement *6 part, the statute reads: programs. er state Researchers use PI Records relative to informa- identify data to pharmaceuti- overuse of a tion containing patient-identifiable and cal in specific populations, develop to new prescriber-identifiable data not shall be drugs, and to facilitate identification of licensed, transferred, used, or sold ... potential patients in participate clinical any for purpose, except commercial for FDA, The trials. the Center for Disease purposes pharmacy the limited of reim- Control, Drug and the federal Enforce- bursement; formulary compliance; care Agency ment PI data use to monitor usage management; by utilization review of controlled to identify substances and provider, health care patient’s insur- prescribers who need safety time-sensitive provider agent either; ance or the of companies information. Insurance and research; health care or as otherwise pharmacy managers benefit use the data provided by law. purpose Commercial to process claims and manage formulary includes, to, but is not limited advertis- Moreover, compliance. compa- insurance ing, marketing, any promotion, or activi- governments nies state and like Vermont’s ty that could be used to influence sales encourage use PI data to of cheap- the use or market share er, generic very medications —the medi- product, influence or the pre- evaluate promote. cations section 17 seeks scribing behavior anof individual health companies While insurance govern- and professional, care or evaluate the effec- data, ments collect their own PI their data- of a professional pharmaceutical tiveness thorough bases are as those main- detailing sales force. mining tained the data appellants. To data, preserve the § value of their data min- N.H.Rev.Stat. Ann. 318:47-f. The stat- statute, ing companies typically ed re-publica- passed restrict intent without they provide tion of the data their legislative custom- formal findings, pro- was to ers. The appellants argue that the tect patient physician privacy sales and and to
269
majority
The
found that
Ayotte,
Health Mills, data to constitutional. be (D.Me.2007), rev’d, Health Inc. v. IMS Cir.2010). (1st Mills, F.3d prohibits the use of PI data Maine statute b. prescri- when the purposes passed In Act In relevant opts part, out its use. ber 17, legislation restricting aimed at the use reads: pharmaceutical marketing. of PI carrier, pharmacy or prescription [A] *7 legislature explained The state that: intermediary may information drug assembly use, general It is the intent of the license, sell, or exchange transfer value, pro- to advance the state’s interest marketing purposes, for for Vermonters, health tecting public of information that iden- prescription drug privacy and protecting prescribers prescriber a has filed con- tifies who for information, prescribing and to ensure fidentiality protection.... private costs are contained health 1711-E(2- 22, § 22 Me.Rev.Stat. Ann. tit. sector, purchas- care as as well for state A). The District Court United States for through ers of prescription drugs, District of found the statute Maine promotion drugs of less and en- costly it did not unconstitutional because survive in- suring prescribers receive unbiased scrutiny despite opt-out intermediate formation. Rowe, F.Supp.2d See provision. 4631(a). 18, § tit. The stat- Vt. Stat. Ann. allowing appeal opt-in Maine ute an adopts approach, an of the district While in to the use of prescribers opt allow pending, court decision was Court See marketing purposes. their PI for for the First Circuit reversed the Appeals 4631(c)(1). Otherwise, § or the sale Hampshire of the district id. judgment New marketing pur- for transfer of PI data upheld constitutionality court marketing use of PI data for Hampshire Ayotte, poses, See or the the New statute. tient, pro- including options, treatment recall purposes, prohibited. The statute notices, safety trials; vides: or or clinical purposes for certain law enforcement as insurer, employ- a A health self-insured by law. otherwise authorized See id. at er, intermedi- an electronic transmission 4631(e)(1)-(7). § ary, entity or pharmacy, a other similar license, sell, exchange shall not or for legislature The state issued containing pres- regulated value records findings in thirty-one legislative support of information, per- criber-identifiable nor 80, § Acts No. the statute. See Vt. mit regulated the use of records contain- (2007). findings expressly The state the ing prescriber-identifiable information legislature’s intent interfere with the for or marketing promoting prescrip- a marketplace of ideas to promote inter- prescriber drug, tion unless the consents example, the state. ests of For the find- (c) provided as in subsection of this sec- ings note that legislature views the tion. Pharmaceutical manufacturers goals marketing as “of- and pharmaceutical marketers shall not ten in conflict goals with the the state.” information prescriber-identifiable use 1(3). § Id. at legislature expressed or promoting prescrip- “marketplace its concern that the for ideas drug prescriber tion unless consents safety on medicine and effectiveness is (c) provided as in subsection this sec- one-sided,” frequently leading doctors to tion. prescribe “drugs incomplete based 4631(d). § Id. at Marketing is defined 1(4). §at biased information.” Id. the statute to include legislature “[pjublic therefore found that
advertising, promotion, any activity health is ill served the massive imba- is intended be used or used to presented lance information to doctors influence or the of a 1(6). sales market share preseribers.” § and other Id. at presci'iption drug, influence or evaluate attempt Section 17 is the state’s to correct behavior prescribing of an individual it sees an marketplace what unbalanced health professional promote care of ideas undermines state’s inter- drug, market prescription health, promoting public ests in protecting drugs patients, or to evaluate the prescriber privacy, reducing health professional effectiveness of pharma- care costs. detailing
ceutical sales force. III. 4631(b)(5). §at
Id. *8 expressly sale, The permits statute the data mining plaintiffs The filed suit on transfer, 29, of PI multiple or use data for August against 2007 the Vermont At- General, other purposes, including pur- enjoin the limited torney seeking enforce- reimbursement; poses of pharmacy pre- the prior ment of statute to its taking scription formulary drug compliance; pa- In effect. November 2007 the action was tient care management; by utilization review consolidated with a suit PhRMA professional, pa- a health care the against appellees seeking the declaratory insurer, tient’s health agent injunctive the ei- An relief. amended com- , ther; research; 14, health care dispensing plaint was filed on May 2008. After a medications; trial, prescription the transmis- bench the court district denied the sion of prescription prescriber plaintiffs’ data from declaratory motions for and in- pharmacy; junctive management; summary care edu- relief and judgment, for provided pa- cational communications to a and denied as moot the defendants’ mo-
271
Sorrell,
is
appellants’ principal argument
The
summary judgment. See
tions
rights
17
their
under
464.
that section
violates
F.Supp.2d at
631
First and Fourteenth Amendments.
17’s
court
that section
The district
found
(“Congress
shall
See U.S. Const. amend.
survived
speech
commercial
restriction
no law ...
the freedom of
abridging
make
Hud
scrutiny under Central
intermediate
”). The
has
speech....
First Amendment
Sorrell,
F.Supp.2d
son. See
applied against
action
been
state
that sec
court likewise found
The district
Fourteenth Amendment. See Gitlow
17 did not violate the dormant Com
tion
York,
New
268 U.S.
45 S.Ct.
of the
States Constit
merce Clause
United
First
(incorporating
Commerce restricts conduct spond that statute court The district found that section speech, than even if the stat- rather speech, is a restriction on and does not it speech ute does restrict commercial merely regulate appellants’ conduct. scrutiny, and that intermediate survives Sorrell, F.Supp.2d at 445-47. See Commerce not violate dormant does appellees argue simply the statute is Because we find that section Clause. practice. on a restriction on commercial improper an restriction buy- They argue that data miners are under the test set forth Central ing selling commodity, which can be Hudson, find unconstitu- we the statute They that the activi- regulated. concede and reverse and remand. tional who pharmaceutical companies ties of the to use that to market
seek
information
DISCUSSION
drugs is
un-
question
a closer
Amendment,
they
First
but
con-
der the
this case
on constitutional
Because
turns
tend that
the statute is nevertheless
issues,
Boy
our review is de novo. See
restriction on
commercial conduct
Dale,
Am. v.
648-
Scouts of
pharmaceutical companies.
(2000);
147 L.Ed.2d
court.
City
agree
We
with the district
v. Bd.
Educ.
Sch.
Melzer
*9
York,
dry
Amendment
City
protects “[e]ven
336 F.3d The First
Dist.
New
of
of
(2d Cir.2003).
information,
185, 198
advocacy, political
devoid of
upheld
cause
for advertise-
court
sections 20
sumer
fraud
of action
3. The district
also
Act,
law.
program
in Vermont
that violate federal
creating
of the
funded
ments
and 21
9,
33, §
Ann. tit.
2004 & tit.
pharmaceutical manufacturers
See Vt. Stat.
a fee on
Sorrell,
462,
2466a;
concerning
F.Supp.2d
464.
professionals
§
health care
educate
holdings
appellants
dispute
these
of
The
do
therapeutic
and cost-effective utilization
medications,
here.
creating
appeal, and we do not address them
a con-
relevance,
expression.”
or artistic
Univer
of Appeals
thought
Court
it would
Studios,
City
sal
Inc.
Corley,
v.
the fabric
]
of the First Amend-
“stretch!
(2d Cir.2001).
429, 446
See also Va. State
beyond any
ment
rational measure” to
Pharmacy
Bd.
v. Va. Citizens Consum
treat a regulation of information different-
Council, Inc.,
748, 761-70,
er
425 U.S.
96 ly
regulation
from a
jerky”
of “beef
when
1817,
S.Ct.
(drug
L.Ed.2d 346
the information is a product.
Id.
53.
price information in drug advertisements
majority
The
Appeals
the Court of
con-
Studios,
speech);
is
City
Universal
273 cluded that it was consistent with the First
F.3d at 446-49 (computer program is Amendment for the “legislature ...
to lev-
speech). Furthermore,
it
plain
is
el the playing
field not
eliminating
speech in a form that is
profit
sold for
but, rather,
speech
by eliminating the de-
entitled to
protection.
First Amendment
ability
tailers’
to use a particular informa-
Bd.,
761,
See Va. State
The Court of Appeals
recently
for
Court
the First Cir-
courts
cuit found that a
do not
Hampshire
similar New
have “freewheeling authority to de-
statute was not a
speech,
categories
restriction on
but
clare new
speech
outside the
primarily
conduct,
a restriction on
scope
al-
of the First Amendment.” United
—
though it considered
only
Stevens,
the statute
as it
U.S.-,
States v.
130 S.Ct.
affected the activities of data
miners rath-
(2010).
id. at 54. Here, legislature explicitly aimed to correct the “massive imbalance Ayotte,
In
the court treated the New
presented
information
to doctors and other
Hampshire
among
statute
the narrow cate-
prescribes.”
1(6).
§
Vt. Acts No. 80
gories
regulations
restricting speech
statute specifically decries that “[t]he
mar
are not entitled to First Amendment
ketplace for ideas on medicine
protection,
safety
the tradition of Chaplinsky
”
effectiveness
frequently
Hampshire,
New
one-sided....
571-72,
1(4).
§
Id. at
The statute
(1942),
86 L.Ed.
is therefore
which
lewd, obscene,
clearly
found
aimed at
profane, libelous,
influencing the supply of
information,
fighting
words to
core First
categories
be
Amendment con
wholly
cern.
outside
Instead of
protections
mere rational
of the
basis re
First
view,
Amendment.
The Court of
First
Appeals inter-
Amendment teaches that
preted the
courts
Hampshire
New
should
statute
assume that
truthful
com
principally a
mercial
regulation of conduct
information “is not in
because
itself harm
ful,”
Bd.,
ability
“restricts]
Va.
data miners to
State
425 U.S. at
aggregate, compile,
and transfer
informa-
and conclude that when a stat
tion
narrowly
destined for
defined
ute aims
com-
to restrict the availability of such
mercial ends” in a transaction where the
information
some purposes,
that re
*10
“information itself has become a commodi-
striction
judged
must be
under the First
ty.” Ayotte,
The
information in
right to access
not
Amendment
conduct and
only regulates
ute
no First
have
files.
appellants
government
because
non-public
to access
right
Amendment
the district court
agree
Because we
with
However,
consent.
without
health records
protected speech,
that the statute restricts
a First
claimed
have not
appellants
whether sec-
necessary
it
to determine
is
obtain information.
right
Amendment
appellants’ First
tion 17 violates the
on their
challenge the restriction
They
rights.
Amendment
information
and use
purchase
ability to
them but for
available
otherwise
II.
prevents
The statute
restriction.
state’s
from
willing buyers
willing sellers
that section 17 re
appellants argue
The
to be used
of information
a sale
completing
though
speech, even
stricts noncommercial
disapproves.
the state
that
purposes
for
They
profit.
argue
for a
PI data is sold
Indeed,
prohibit
not
17 does
subject
should be
to strict
that the statute
not
long as
PI data so
collection
Bd.
State Univ.
scrutiny. See
of Trs. of
pro-
the state has
purposes
used
Fox,
109 S.Ct.
N.Y. v.
hibited.
(“Some
3028, 106
of our
L.Ed.2d 388
Supreme
rely on
appellees
The
fully protected
valued forms of
most
Police
Angeles
in Los
decision
Court’s
profit.”)
The
speech are uttered for
Publish
Reporting
v. United
Department
contend,
the district court
appellees
U.S.
ing Corp., 528
only com
that section 17 restricts
agreed,
(1999). However, that case
L.Ed.2d
subject to
and therefore is
speech,
mercial
argument is
appellees’
why
illustrates
scrutiny under the test set
intermediate
Reporting,
Su
In United
misplaced.
Sorrell,
See
out
Central Hudson.
on ac
that restrictions
held
preme Court
court
at 447-48. The district
F.Supp.2d
infor
department
police
to certain
cess
commercial
data has both
noted
PI
facially
unconstitutional
were
mation
Sorrell, 631
uses. See
and noncommercial
Id.
34-
First Amendment.
under the
can be used in
at 447. The data
F.Supp.2d
Supreme
Court
Stat. tit. We address debate’ is not entitled to the protection each in turn. constitutional afforded noncom- speech.”); mercial Frog Brewery, Bad Inc. a. Auth., 87, v. N.Y. Liquor State 134 F.3d 97 (2d Cir.1998) (holding product label to be pharmaceutical Section 17 prohibits despite commercial social commen- using PI data regard- manufacturers from tary purportedly communicated by the la- ing prescriptions dispensed written and in beling). Vermont in their efforts. See id. The statute therefore affects manufac- Therefore, although some of the ability promote turers’ brand-name information communicated detailers drugs through detailing, to doctors for ex- might fully be protected another ample, by making identify harder context, analyze we will section 17 as a physicians those for whom the message restriction on commercial speech with
will be most relevant and to tailor the
respect
pharmaceutical
manufac
detailing
based
messages
on individual
68,
turers.
Bolger,
See
a.
thermore,
not ban
use
the statute does
marketing pur-
other than for
of the data
of Central Hudson
prong
The second
widespread publication to
including
poses,
a substan-
the state “assert
requires that
nothing
There is
public.
general
restrictions
achieved
tial interest to be
the use of
prevent
that would
al-
the statute
Id. Vermont
speech.”
on commercial
journalistic
such
reports
ny requires
about
the state “demonstrate
physicians.
that the harms it recites are real.” Rubin
*13
Co.,
v.
Brewing
Coors
514 U.S.
contemplates
the data will
(1995).
1585,
115 S.Ct.
privacy”
actually
two distinct interests.
b.
The first is an interest in the integrity of
prong
third
of Central Hudson re
itself,
the prescribing process
and the sec- quires that
the regulation “directly ad
ond is an interest
in preserving patients’
vance the state interest
involved.” Cent.
trust
their
preventing pa-
doctors
Hudson,
564,
2343;
However, the state’s asserted inter
as “whether
challenged
regulation ad
est in
privacy
medical
is too speculative to vances
these interests
a direct
ma
qualify as a substantial state interest un
terial way”). “It is well established that
der Central Hudson.
Intermediate scruti-
‘the party seeking to
uphold
restriction
less
practices
carries
burden
will be
effective and less
speech
on commercial
likely to
Edenfield,
prescribing practices
it.’”
influence
justifying
U.S.
(alteration omitted)
physicians.
770,
c. merely drugs brand-name new final fails under 17 also Section medications for which those brand-name Hudson, requires which of Central prong generic there are alternatives. govern- “if the
invalidating the restriction
argue that
the Court
appellees
*16
could
served as well
mental interest
be
legislative
to the
determina-
should defer
on commercial
a more limited restriction
a
fit
tion that the statute is
reasonable
so
564,
at
matter how and regard prescriptions break- even with categorical a ban. renders the statute medications for which through brand-name alternatives, and be- generic there are no explain failed to how sec- appellees alternative pursue cause the state could no more extensive than neces- tion 17 is directly targeted at encour- in routes that are its asserted interests sary to serve health, generic drugs the state aging the use public care costs and health the state has not dem- promote, be wishes to alternatives would why proposed protecting its interests limited onstrated inadequate. present The state did health care containing and public alter- health testimony relating at trial to these I. costs could not be as well served on speech. more limited restriction begin I with ground: common there is Therefore, section 17 cannot survive inter dispute prescriber-identifiable no scrutiny is an unconstitutional mediate and i.e., pre data which documents the data — regulation of commercial under the (“PI scribing particular habits of a doctor test set forth Central Hudson.5 data”) exceptionally phar valuable to —is CONCLUSION companies, maceutical who make use of it to market highly profitable their brand above, explained For reasons we drugs through process name known as judgment reverse remand the of the “detailing.”2 dispute There also is no court. district marketing messages “detailers” deliver LIVINGSTON, DEBRA ANN Circuit meetings with pro doctors constitute Judge, dissenting: activity. tected First Amendment Finally, dispute there is no that section 17 does not
Misconstruing
prescription
Vermont’s
directly
law,
regulate
messages
those
or the
confidentiality
Vt. Stat. Ann. tit. 18
(2007) (hereinafter
17”),1
§
marketing practices
Maj. Op.
“section
of detailers.
Instead,
pharmaceutical
as a direct restriction on
regulates
at 277.
Vermont’s law
marketing,
indisputably
which is
a form of
the dissemination of confidential informa
speech”
purposes
“commercial
of the
specifically, PI
pro
data —and the
tion—
Amendment,
First
majority
extends
cess
which
is collected and sold.
First
protection
Amendment
to data min-
targets
process
Because section 17
pharmaceutical companies princi-
ers and
itself,
detailing
rather than
“understanding
pally challenging a restriction on access to the sequence of events” section 17 regu
private
otherwise
In
information.
so do-
is,
process by
lates —that
which PI
ing,
majority
reaches the
prescription pad
travels
case,
wrong result in this
but creates Cir-
hands of a
detailer—-“is
precedent
likely
cuit
pernicious
to have
understanding
crucial to
legal
the statute’s
complex
broader effects in a
evolving
Mills,
status.”
IMS Health Inc. v.
area of First Amendment law. Because I
(1st Cir.2010)
J.,
(Lipez,
F.3d
concur
would find that section 17 permissibly re-
ring
part
dissenting
part).
stricts access to information that law,
requires
every
Pursuant
to Vermont
pharmacies to collect and that
time a
limited,
very
pharmacy
statute has
if
any,
effects on
fills
within the
state,
First Amendment
activity,
respectfully
required
it is
to collect certain infor-
dissent.
doctor,
mation about the
patient,
appellants
argue
5. The
also
Analytics,
(collectively,
that section 17
Healthcare
Inc.
mining
violates the dormant Commerce
appellants”).
Mining Ap-
Clause be-
"data
Data
*19
cause it restricts
pellants’
commerce outside Vermont.
Br. at 2.
we
Because
find section 17 unconstitutional
below, "detailing”
test,
As discussed further
pursuant to the Central Hudson
we need
promotion
involves the face-to-face
of a
argument.
not reach this
particular
drug by
repre-
brand name
sales
captioned
1. While the Vermont law is
"Confi-
sentatives —known as "detailers” —who are
information,”
dentiality
prescription
employed by
pharmaceutical company
it is
the
disingenuously
"Prescription
drug
referred to as a
that manufactures and distributes that
by plaintiffs-appellants
Restraint Law”
in-person
physicians
IMS
and make
visits to
Inc.,
LLC,
Verispan
Health
purpose
promotion.
and Source
the
of such
See,
majority
the
focuses on
being prescribed.
medication
the
Rules
least
three events take
Pharmacy Admin.
ever occurs—at
Bd. of
e.g., Vt.
(eff.Oct.2009).3
first,
Because
9.1, 9.24,
gathers
informa-
place:
pharmacy
9.26
§§
is so valuable
prescrip-
information
to fill
patients seeking
tion from
including the
parties,
of third
tions; second,
number
it collects and sells that data
case, pharma
in this
plaintiffs-appellants
third parties, principally “data vendors”
time,
practice
made a
cies,
have
for some
here;
appellants
miners” such as
or “data
knowledge
the
selling it—often without
third,
repackage
these data miners
and
doctor,
alone the
let
permission
or
pharmaceutical
and license it to
that data
including
parties,
third
patient
various
generally
—to
IMS Health
companies. See
plaintiffs-ap
mining vendors such
data
(1st
Ayotte,
48-49
Inc.
Inc.,
LLC,
Verispan,
IMS Health
pellants
Cir.2008). Only after these three transac-
(collec
Analytics
South Healthcare
and
PI
land in the hands
tions occur does
data
mining appellants”).4
tively,
the “data
it to facilitate
of detailers who then use
compile the
aggregate and
These vendors
detailing
their
efforts.
and
acquire
pharmacies
from
they
data
by
sequence of events
Troubled
this
compa
license
then
whereby otherwise confidential
informa-
nies,
plaintiff-appel
here
represented
up
pharmaceuti-
tion ends
in the hands of
Research and Manu
lant Pharmaceutical
response
cal
and in
to concerns
(“PhRMA”),
detailers
who use
of America
facturers
(2)
(1)
privacy,
medical
threats to
guide some of their
about
information to
and,
health,
patient
rising
their “detail
and
health care
marketing
particular,
Specifically, pharmaceutical
widespread use of
ing” efforts.
costs attributable to the
(which
identify particu
PI data to
companies
prescription drugs
use
name
new brand
“detailing,” to monitor
lar doctors for
likely
record indicates are those most
efforts,
detailing
and to
of their
success
subject
detailing
of extensive
to be the
detailers based
compensate
efforts)
individual
prescription
Vermont enacted its
by the doctors
prescriptions written
part,
In
confidentiality law.
relevant
detailers
meet with. Pharmaceutical
they
insurer,
prohibits any
[ ]
law
“health
self-
not, however,
directly reference
do
employer,
electronic transmis-
[]
insured
doctors,
meetings with
in their
intermediary,
pharmacy, or other
[]
sion
fact,
so
doing
from
prohibited
are
entity”
“selling],
licensing],
similar
licensing agree
employers’
terms of their
or otherwise
exchanging]
for value”
[]
mining appellants.
the data
ments with
“permitting]
“preseriber-identi-
the use” of
pro-
or
fiable information for
sets
Accordingly, before a detailer ever
is,
drug” absent
moting
office—that
before
foot in a doctor’s
patient's
to track the
use of a
http://
the data miners
rules are available
3. The state
vtprofessionals.org/oprl/pharmacists/rules/
drug
drugs
this
over time and
associate
source,
20Adopted%
20Effec-
Pharmacy%
payment
20Rules%
given prescriber,
use with a
201,% 202009% 20PDF%
tive% 20October%
Accordingly,
pharmacy.
even as "de-
18, 2010).
(last
20Version.pdf
Nov.
visited
identified,”
purchaser
the data is such that
50-year-old woman who
would know that “a
commonly
includes
sold
4. The information
Vermont;
prescriptions
lives in Central
has
name,
address; prescriber’s name and
patient
Montpelier;
is a
of Dr.
[and]
filled in
drug prescribed;
dosage,
quantity
regularly
Montpelier ...
takes an
Jones in
prescrip-
at which the
date and location
cholesterol-lowering
antidepressant
and a
filled;
patient's age
and the
tion was
*20
Respondents'
drug.”
Br. at 7.
encrypted,
patient’s name is
but
gender. The
permits
personal data still
"de-identified”
this
prescriber’s
pro-
consent. The law further
the data miners
com-
“pharmaceutical
hibits
manufacturers and panies before the Court.6
“us[ing] prescriber-
[] marketers” from
restriction,
In
considering
begin
I
marketing
identifiable information for
or
undisputed
with the
fact
that Vermont
promoting
prescription drug”
unless
pharmacies have
pre-
access to and collect
prescriber
provid-
consents in the manner
scription
information
under the di-
by
18,
ed
statute. Vt. Stat. Ann.
tit.
authority
rection and
of state law. As
4631(d).
§
noted,
requires pharmacies
Vermont
to
restriction,
Focusing heavily on that last
collect information such as the name of the
majority begins
analysis
its
at the end
doctor,
prescribing
age
the name and
i.e.,
“sequence
of the
at the
events” —
patient,
drug
and the
pre-
and dose
point
already
at which PI data is
in the
Having
scribed.
mandated the collection
of pharmaceutical companies
hands
—and
of that
highly
otherwise
confidential infor-
impermissibly
concludes that the law
“re- mation, the state unquestionably has an
pharmaceuti-
stricts the
of both the
interest
in controlling its further dissemi-
cal manufacturers ... who
prohibited
are
nation.
It is that interest that section 17
using
from
data for
respect
effectuates —with
appellants,
to
purposes, and the
mining appellants,
data
operates
Vermont’s law
principally
pre-
prohibited
who are
from selling or trans-
vent them
obtaining
from
pri-
otherwise
ferring Vermont PI data if the data is to
data,
such,
vate PI
and as
does no more
be used
marketing purposes.” Maj.
than restrict their unfettered access to in-
law,
Op.
however,
at 273. The
starts at
formation. This the First Amendment
beginning,
and seeks to cut off the
Rusk,
permits.
1,
See Zemel v.
of PI
flow
data at its source: section 17 17,
ignores the fact that section
Vermont’s
I
speech.
the flow of PI data well before it ever
lates conduct or
Because
view
importance,
“in
one
appellants.
comes to be
the hands” of
that issue as
of some
Indeed,
law,
operation
appel-
deeply
by
under
of the
because I am
troubled
the ma-
it, I, too,
they
jority’s
PI
if
have
address the
possess
lants can
data
discussion
pharmacies
express
obtained it from
on the condi-
issue
order
considerable
that,
“marketing
applied
mining
tion that
not be used for
or
as
to the data
doubt
promoting
prescription drug.”
particular,
of a
Hav-
can
appellants
section 17
PI data with
ing
properly
thus obtained
conditions
be characterized as
restriction
attached,
clearly
cannot
appellants
speech.
considering
ap-
subse-
In
the law as
quently
plied
contend those conditions amount
to data
miners
they
companies,
again reject
majori-
to restrictions on information
“al-
I once
ready possess.”
ty’s approach
“sequence
and follow the
here,
regulates, beginning,
events” the law
question
proposition
I do not
applied
with the restriction as
to the data
apply
different considerations
where the
miners.
government
“prohibiting
speaker
from
conveying
speaker
information that
al
preliminary
As a
matter —overlooked
ready
I
possesses.”
simply conclude that
majority
parties dispute
whether
—the
appellants
none of the
in this case are so
actually
section 17
min-
restricts
by operation
affected
of section 17. Nor
Indeed,
ers at all.
section 17 makes no
pass
do I
on the
pressed
concern—not
mention of data miners or vendors. Ac-
appellants here —that selectively restrict
cordingly, it is not clear to me that data
ing
may
access to information
raise First
miners have
interests —First Amend-
Reporting,
Amendment concerns. United
ment or otherwise—at stake here. Section
(Scalia, J.,
II. fer is made “for marketing promoting Because I thus conclude that section 17 drug,” and because a data upheld should permissible be as a restric- conceivably miner could be deemed a “sim- information, tion on access to I entity” could end ilar regulated, pro- thus so my analysis however, majority, there. The might ceed to consider the law as it be proceeds whether, question to the applied to them. (Sack, J.), that the com where we found thus, that re- is whether question, there did not infringes program question
striction,
imposed,
puter
it be
should
*23
rights.
protection
First Amendment
First Amendment
warrant
miners’
data
by
to conclude
reasons
that “the values served
significant
ground
are
There
majority con-
by
As the
not.
were not advanced
it does
First Amendment
disingenu-
cedes,
miners —who
(citing
data
these
Id. at 449
code].”
Vartuli
[the
Vartuli,
for
“publishers”
style
111);
themselves
ously
at
see also
228 F.3d
Vartuli
not them-
litigation-
this
of
purpose
(noting
at 111
that those “values”
228 F.3d
—“do
in
“are
PI data” but instead
use
selves
truth,
of
the accommo
pursuit
include “the
selling data.”
and
aggregating
of
business
interests, the achievement of
among
dation
Nevertheless,
our
citing
Maj. Op. at 274.
and deter
stability,
exposure
social
City
proposi-
for the
in
opinion Universal
authority, personal au
rence of abuses of
protects
First Amendment
“[t]he
tion that
tonomy
personality development, [and]
information,
advocacy,
devoid of
dry
‘even
democracy”).
functioning
of
”
relevance,
expression,’
or artistic
political
in
Accordingly,
question
ap
the critical
City
(citing
Maj. Op. at 271-72
Universal
merely
plying
City
Universal
is not
wheth
446) (alteration
Studios, Inc.,
at
273 F.3d
engaged in the
appellants
er the
are
sale
omitted),
majority concludes that the
rather whether
“dry
information” but
“dry information”
miners’ sale of that
data
“dry
informa
they
engaged
are
a sale
imply-
speech, even
protected
constitutes
tion” that
the “values served
“advance[s]”
non-commercial
may
that it
constitute
ing
Vartuli,
Amendment.”
the First
Cf.
271,
speech. Id.
(“Language
at 111
serves a vari
228 F.3d
City
support
I do not read Universal
functions, only
of which are
ety of
some
There, we
sweeping proposition.
such
special
covered
reasons for freedom
dry
that “even
informa
in dicta
observed
Greenwalt,
(quoting Kent
speech.”)
held,
“speech” and
may
protected
be
tion”
Crime, 4
B. Found.
Speech and
Am.
Res.
con
“computer programs
specifically,
(1980)). Here,
645,
strong
there are
J.
can merit First
code[ ]
structed
min
question whether the data
reasons to
446,
273 F.3d
protection,”
Amendment
engaged
are
conduct
ing appellants
added);
at 445
see also id.
(emphasis
majority
meets that standard. As
age,
in the modern
this Court
(noting that
them,
mining appel
characterizes
the data
...
‘evolutionary’ approach
“an
has taken
aggregating
lants are
the “business
per
holdings
‘narrow
that would
favoring
which communi
selling
data”—data
‘case-by-case’
to mature on a
mit the law
them
nothing about them nor allows
cates
basis”)
Net
Name.Space, Inc. v.
(quoting
at all.
anything
or communicate
express
Solutions, Inc.,
573,
n.
202 F.3d
work
Maj.
at 274.
Op.
Cir.2000)).
(2d
the facts of
On
clear,
dry
To
the dissemination
be
case,
computer
that the
code
we concluded
First Amend-
qualify
information can
First Amendment
question
warranted
instance, as we ob-
protection.
ment
For
capacity
it had the
because
protection
City, “courts have
served
Universal
beings
to human
communicate information
scrutiny re-
subjected to First Amendment
among
both “discourse
promoted
and had
on the dissemination of technical
strictions
“exchange
computer scholars”
re-
information and scientific
scientific
How
Id. at 448.
expression.”
ideas and
at 447
City, 273 F.3d
search.” Universal
ever,
distinguished
we
Com
doing,
in so
(internal
omitted);
Miller
citations
see also
v.
modity
Trading
Futures
Commission
(2d Cir.2000)
California,
Vartuli,
(1973) (“The
concluded,
political,
(emphasis
value.”
scientific
hand,
majority rejects,
out of
added)).
here,
But
mining appellants
jerky”
First Circuit’s
analogy
“beef
appeal
do not contend on
that section 17 labels “obscure” its distinction between
precludes
distributing
them from
data to
speech and “information
asset[s].”
do
foster scientific or medical research. To
not necessarily mean to endorse that
*24
contrary,
to the extent Vermont’s law
approach
court’s
or even its ultimate con
applies
all,
to
merely prevents
them at
it
clusion. But I am deeply
troubled
them from licensing their data for a single
fact
majority opinion
that the
be
—which
use—the marketing
drugs.
comes the
opinion
first circuit-level
to hold
mining
Nor do data
appellants contend the
that data miners’ sale of PI data consti
prohibits
statute
fostering pub-
them from
tutes First
activity7
Amendment
—does
opinion
lic
contrary,
or debate —to the
as
engage
even bother to
in the funda
above,
mining
noted
data
appellants actu-
analysis
mental First Amendment
our case
ally prohibit their customers from disclos-
requires.
law
majority
offers no co
ing
else,
they
anyone
data
license to
gent
why
“dry
reason for
this
information”
such,
much
general public.
less the
As
falls into the category the First Amend
difficulty
have some
comparing the data
protects,
ment
any
nor
discussion of how
they sell to
“exchange
“discourse” or the
“dry
this
information” can be deemed to
ideas.”
“advance” the
“values served
the First
Circuit,
The First
evaluating
in
a similar
Vartuli,
Amendment.” See
228 F.3d at
law,
just
concluded that PI data was
111.
product, not distinguishable from the data
reiterate,
To
question
I do not
dry
that
miners’ perspective
widgets, or,
to
as the
information may be of First Amendment
First
suggested,
Circuit
jerky.” Ay
“beef
importance given the role information fre
otte,
such,
F.3d
53. As
the court
quently plays in forming public opinion or
found that “this is a situation in which
fostering
marketplace
of ideas.
In
information itself has become a commodi
deed, dry information —in the form of a
ty”-
53;
“informational asset.” Id. at
—-an
professor’s research or a programmer’s
Condon,
Reno v.
cf
may frequently be of core First
(2000) (sale
(“[T]he [Supreme] rejected Court has argument scrutiny that strict apply should III. regulations ..., speech however, Finally, even if I were to con- adhering instead to the somewhat rig- less 17’s total effect on clude de- (col- orous standards Central Hudson.” sufficient constitute a re- tailing was cases)). lecting speech, I on commercial would striction uphold statute because I nonetheless a. complies with the find that stan-
would
respect
factor,
With
to the first
in Central Hudson.
dard set forth
identifies three “substantial interests” sec-
(1)
tion 17 advances:
an
“pro-
interest
Hudson,
regulate
Central
com
Under
(2)
tecting
public health,”
an
interest
mercial
is “neither misleading
“protecting
privacy
prescribers
activity,”8
nor related to unlawful
gov
(3)
information,”
prescribing
an inter-
(1)
ernment must
assert a “substantial in
est in “ensuring] costs are contained” in
achieved,
terest” to be
and demonstrate
the health care sector.
majority
con-
(2)
“directly
the restriction
advances”
cludes that the first and third constitute
interest,
the limitation “is not
“substantial” state interests but that the
more
necessary
extensive than
to serve
second is “too speculative”
qualify.
that interest.” Cent. Hudson Gas & Elec.
*26
Maj. Op. at 275-76. I would conclude that
Comm’n,
Corp.
557,
v. Pub. Serv.
447 U.S.
all three constitute “substantial” state in-
564-66,
2343,
100 S.Ct.
291
regulation
at issue “direct
directly ques
er whether
majority does not
which
ly advances” the asserted state interests
Indeed,
appellants nor
neither
tion.
as well as whether the restriction “is not
argument
serious
majority advances
necessary
than
more extensive
serve
legitimate
have a
state does not
that the
Hudson,
Cent.
447
th[ose] interest[s].”
privacy,
in medical
interest
and substantial
564, 566,
that its law furthers at least one interest
exercise of
Li
way,”
“in
Island,
a direct and material
Inc. v.
quormart,
Rhode
517 U.S.
Edenfield
Fane,
761, 767,
1792,
507 U.S.
113 S.Ct.
484, 508,
116 S.Ct.
134 L.Ed.2d
(1993),
accordingly
123 L.Ed.2d
(1996) (plurality opinion), and cautioned
we ask whether the state has demonstrat-
that,
legislature
where a
has deemed a
ed “that the harms it recites are real and
particular
regulation
properly
tailored
them
[the
will alleviate
restriction]
interest,
response to
substantial
“we
Anderson,
a material degree.”
second-guess
have been loath to
[g]ov
(internal
quotations
at 462
citation and
Fox,
judgment
ernment’s
to that effect.”
omitted).
evaluating
gov-
In
whether the
As Turner did *28 government stead ask “whether the is able not address restriction on commercial support to its restriction on speech, speech by a context in which Supreme Court, adducing] empirical either Turner, support or at independent of has re reasoning least sound peatedly urged behalf of its legislative deference to (Li findings. Ayotte, measure.” 550 Ayotte, (Lipez, See F.3d 93 F.3d J., J., pez, concurring in concurring part and part dissenting dissenting and (“[T]he (internal in part) general part) quotation principle legisla marks and altera- omitted) added); tive deference” articulated in Turner tions (emphasis “also see also (“A compatible is with the Court’s id. at 55 state go beyond commercial need not speech precedent.”). Specifically, demands of common sense to show that a Court has found that promises directly commercial statute to advance an speech doctrine allows “some room for the government identified (citing interest.”
Central
finding
Hudson controls
ground”).
"no need
in this case to break new
Freeman,
191, 211,
Channel,
v.
504 U.S.
112 rect.’”
Burson
Clear
295
data,
found,
finding that,
with
stricts commercial
respect
pharmaceu-
speech—a
above,
companies
mining appel-
the data
as set forth
I
tical
are
doubt—the restriction
Sorrell,
“only
imposed
both
paying
lants’
customers.”
is
minimal
indirect. At
most,
important,
indirectly
17
F.Supp.2d
631
More
section
limits the mes-
sage
by
convey
preventing
what amounts to an “underinclusiveness”
detailers
them
availing
“tailoring”
in
from
message
is not
the context of
their
on a
argument
based
Hudson,
require
particular
not
past
which does
doctor’s
habits.
prescribing
Central
de
scrutiny.
Posadas
Puerto The law does not otherwise affect the mes-
strict
See
Assocs.,
deliver,
sage they
directly
Rico
478
106 S.Ct.
nor does it
re-
U.S.
(1986) (statute’s
way.
Indeed,
strict
detailing
L.Ed.2d 266
“un-
as
notes,
controlling
majority
not
of de-
section
not
...
derinclusive[ness]”
“does
“directly
directly
marketing
termination as to whether it
ad-
restrict the
practices
interests);
Channel,
Maj. Op.
state
Clear
detailers.”
at 277.
vances”
(“[T]he Supreme
at 110
Court
Given that minimal and indirect burden
clear
has made
that underinclusiveness
on speech, section 17
inherently
is
distinct
defeat a claim that
necessarily
will not
“categorical”
the sorts
and direct
materially
stat
interest
been
ad-
has
Supreme
bans on commercial
speech
vanced.”). All that Central Hudson de-
previously
Court
struck
has
down. See
regulation materially
is that a
mands
ad- Ayotte,
(Lipez, J.,
d.
Supreme
complete
It
neither
Court.
is
advertising
ban on
of a
The third Central Hudson factor re-
product
... nor a
prohibition
blanket
on
quires consideration whether
statute
(internal
solicitation.”)
in-person
citations
necessary
is “not more extensive than
omitted).
It is with that
limited
serve” the
state interests.
burden
asserted
Be-
imposed
mind,
cause,
noted,
by section 17
I
tailoring”
this “narrow
“proportion[ality]”
consider the
of the law.
requirement
is not
“least restrictive
test,
fit “that
means”
we look
for a
I would find that the minimal and indi-
necessarily
not
but
perfect,
reasonable”
rect
imposes
burden section
on
and ask whether
the restriction is one
is not
than
necessary
“more
to further”
scope
proportion
“whose
is in
inter-
government’s
three asserted interests.
est served.” Greater New Orleans Broad.
Channel,
Clear
at 104 (quoting
F.3d
Ass’n,
restrictive
“narrowly
not
be-
section 17 is
tailored”
sug-
example,
mining appellants
the data
“less
cause
failed to consider
“limit
Vermont
the
could instead
advertis-
gest
state
Maj.
speech-restrictive means available.”
were unnec-
that it concluded
ing
drugs
noted, among
Op. at
As
those “less
majority
280.
essarily
expensive,” while
majority
speech-restrictive” measures
generic
“mandatfing] the use
suggests,
generic
the use of
posits
mandating
are
... for
drugs as a first course of treatment
drugs. Alternatively,
majority sug-
Part
receiving
those
Medicare
patients
all
that, among
things,
gests
other
Maj. Op.
The
D funds.”
at 280.
state
of a
could await
results
“counter-
regulation
promotes
a
that
adopted
instead
adopted by the
speech”
already
measure
directly regulat-
all three interests without
First, none of these “less restric-
mes-
state.
ing speech or the content of detailers’
tive”
would
all three state
means
address
sages,
unduly interfering
without
such,
further the
As
interests because none would
prescribing
habits of doctors.
in protecting
a
state’s substantial
interest
regula-
I
find it to be
“reasonable”
would
grounds
alone is
choice,
privacy.
that
medical
That
tory
one
deserves deference
Channel,
not
seri-
accepting
594
state’s decision
to
from this Court. See Clear
ously pursue
those
alternatives.
F.3d
104.
Cf.
Ctr.,
Thompson v. Western States Med.
17
majority
contends
section
152
“narrowly
cannot
tailored” be-
be deemed
(2002) (“[I]f
the Government
L.Ed.2d
cause it
in several re-
is overinclusive
could achieve its interests
a manner that
First,
spects.
majority
contends that
speech
does not restrict
...
the Govern-
ap-
because it
section 17 is over-inclusive
so.”).
ment must do
regard
plies “without
to whether the
second,
above,
as
of the
many
But
noted
drug that
pertains
to a
is effi-
less
ma-
speecA-restrictive alternatives the
However,
Maj. Op. at
cacious.”
are,
jority
considers
be “available”
very harm
is
section
seeks
avoid
fact,
ap-
far more
on
intrusive restrictions
aggressive marketing
drugs whose effi-
pellants’
practices
pre-
or
business
doctors’
cacy
drug
is
yet
not
known because
scribing habits. And while Central Hud-
subject
not
actual
has
been
much
use
progeny
son and its
make clear that
Alternatively,
ma-
patient experience.
may
state
default
restric-
jority
is over-
contends
section
other,
tions
effective reme-
equally
where
it
inclusive
even where no
applies
because
available,
body
dies are
I do not read that
generic alternative exists or where a new
require
adopt
more
law to
state
far
drug
“unique.”
majority’s analysis,
is
simply
restrictive and intrusive measures
however, overlooks the state’s third as-
the less
im-
because
restrictive measure
in protecting
serted interest —that
medical
speech.
poses an incidental burden
overlook that
privacy. Because
do not
where,
interest,
here,
reject
Finally,
leg-
is
I would
overinclusive-
state
both
heavily
arguments
already
regulated
on the
within an
ground
islating
ness
field,
protecting
particular
owe
deference to the
furthers
state interest
we
by prohibiting
specific regulatory
medical
choice the state makes.
privacy
transfer
Anderson,
Especially
irre- See
at 463.
marketing purposes
data for
F.3d
context,
drug
not the
of this
spective of whether the brand-name
role
being
generic
guess”
legislature’s
has a
Court to “second
de-
detailed is effective or
equivalent.
regulatory approach
cision as to which
*32
297
Fox,
(2008),
S.Ct.
170
685
prohibits
492
109
L.Ed.2d
best.
U.S.
See
Channel,
It
3028;
regulating
594 F.3d at
states from
occur
105.
“commerce
Clear
instead,
ring wholly
to
is,
[a]
our role
ensure that
outside
State’s borders.”
Inst.,
324, 332,
“reasonably
v. Beer
491
propor- Healy
chosen is
U.S.
109
restriction
(1989).
it
the interests
furthers. Section S.Ct.
IV. them of in- relieve restrictions on their I appellants’ Because would find that state of that data and re- purchase in-state fails, challenge briefly Amendment I First Mills, sale of that data. Cf. mining appellants’ the data addi- address (finding “implicates similar Maine statute tional Commerce Clause chal- dormant none” the “concerns central to the [] lenge. reject challenge I would as way Supreme Court has framed the well, substantially the reasons cogently dormant Clause in recent Commerce its Sorrell, set forth the district court. See opinions”). F.Supp.2d at 457-59. Accordingly, I would find no basis so-called “dormant Commerce jurisprudence dormant Commerce Clause Clause,” im- “negative which refers to the statute. disturb Vermont’s
plication” Supreme long Court has against interference in Con- drawn state V. authority gress’ regulate constitutional commerce, Dep’t striking majority interstate Revenue In down Davis, Ky. statutory 128 S.Ct. not ban on U.S. misconstrues Accordingly, sponse its statute effects. as a private information access to *33 respectfully dissent. restriction, from the law but it then breaks Court, first, labeling data miners’ in this protected First “dry information” sale second, and, in activity, apply-
Amendment of Central Hudson
ing aggressive an form legis- insufficient deference
that affords findings As
lative and determinations.
result, sign not on either I cannot and do JENKINS, Petitioner-Appellant, or manner majority’s outcome Taiwu it thereto.
by which arrives above, transfer of has noted As Gary GREENE, Respondent-Appellee. business, with those burgeoning become 09-3623-pr. No. Docket frequently in hav- engaged such transfers engaging expressive no intention of ing Appeals, United States Court For the rea- communicative conduct. Circuit. Second above, am unwilling forth I sons set April 2010. Argued: majority’s conclusion that such accept the Dec. Decided: right operations have an inherent business as a shield invoke the First Amendment regulation simply be- against reasonable “dry informa-
cause their business deals Moreover, I dry goods. rather
tion” than majority’s that the
express serious concern First of the Amend-
discussion interests here but also of the
ment at issue imposed by Central Hudson will
standard unduly inappropriately diffi-
make properly
cult for states to and constitution-
ally regulate furtherance substantial
interests, very including a state’s serious private in the infor- protection
interest
mation. 17 as legiti-
I thus section would affirm
mate restriction on access information few, any, commercial conduct with if on First Amendment ac-
attenuated effects
tivity. Alternatively, even were I to con- First
clude restricts activity, applying
Amendment Central
Hudson, greater far would afford defer- eminently legisla- to the reasonable
ence judgments
tive the state has made here in- substantial state
furtherance several reasonably proportional re-
terests and
